321 related articles for article (PubMed ID: 7972823)
1. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique.
Boetes C; Barentsz JO; Mus RD; van der Sluis RF; van Erning LJ; Hendriks JH; Holland R; Ruys SH
Radiology; 1994 Dec; 193(3):777-81. PubMed ID: 7972823
[TBL] [Abstract][Full Text] [Related]
2. Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results.
Jager GJ; Ruijter ET; van de Kaa CA; de la Rosette JJ; Oosterhof GO; Thornbury JR; Ruijs SH; Barentsz JO
Radiology; 1997 Jun; 203(3):645-52. PubMed ID: 9169683
[TBL] [Abstract][Full Text] [Related]
3. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis.
Buadu LD; Murakami J; Murayama S; Hashiguchi N; Sakai S; Masuda K; Toyoshima S; Kuroki S; Ohno S
Radiology; 1996 Sep; 200(3):639-49. PubMed ID: 8756909
[TBL] [Abstract][Full Text] [Related]
4. Peripheral washout sign on contrast-enhanced MR images of the breast.
Sherif H; Mahfouz AE; Oellinger H; Hadijuana J; Blohmer JU; Taupitz M; Felix R; Hamm B
Radiology; 1997 Oct; 205(1):209-13. PubMed ID: 9314987
[TBL] [Abstract][Full Text] [Related]
5. Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions.
Mahfouz AE; Hamm B; Wolf KJ
Radiology; 1994 Jan; 190(1):49-52. PubMed ID: 8259426
[TBL] [Abstract][Full Text] [Related]
6. Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging.
Kuhl CK; Bieling H; Gieseke J; Ebel T; Mielcarek P; Far F; Folkers P; Elevelt A; Schild HH
Radiology; 1997 Jan; 202(1):87-95. PubMed ID: 8988196
[TBL] [Abstract][Full Text] [Related]
7. Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions.
Hawighorst H; Knapstein PG; Schaeffer U; Knopp MV; Brix G; Hoffmann U; Zuna I; Essig M; van Kaick G
AJR Am J Roentgenol; 1996 Feb; 166(2):401-8. PubMed ID: 8553955
[TBL] [Abstract][Full Text] [Related]
8. Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging.
Hamm B; Thoeni RF; Gould RG; Bernardino ME; Lüning M; Saini S; Mahfouz AE; Taupitz M; Wolf KJ
Radiology; 1994 Feb; 190(2):417-23. PubMed ID: 8284392
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine.
Heywang-Köbrunner SH; Haustein J; Pohl C; Beck R; Lommatzsch B; Untch M; Nathrath WB
Radiology; 1994 Jun; 191(3):639-46. PubMed ID: 8184040
[TBL] [Abstract][Full Text] [Related]
10. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations.
Kaiser WA; Zeitler E
Radiology; 1989 Mar; 170(3 Pt 1):681-6. PubMed ID: 2916021
[TBL] [Abstract][Full Text] [Related]
11. Breast disease: tissue characterization with Gd-DTPA enhancement profiles.
Stack JP; Redmond OM; Codd MB; Dervan PA; Ennis JT
Radiology; 1990 Feb; 174(2):491-4. PubMed ID: 2296657
[TBL] [Abstract][Full Text] [Related]
12. Benign and malignant musculoskeletal lesions: dynamic contrast-enhanced MR imaging--parametric "first-pass" images depict tissue vascularization and perfusion.
Verstraete KL; De Deene Y; Roels H; Dierick A; Uyttendaele D; Kunnen M
Radiology; 1994 Sep; 192(3):835-43. PubMed ID: 8058957
[TBL] [Abstract][Full Text] [Related]
13. Staging urinary bladder cancer after transurethral biopsy: value of fast dynamic contrast-enhanced MR imaging.
Barentsz JO; Jager GJ; van Vierzen PB; Witjes JA; Strijk SP; Peters H; Karssemeijer N; Ruijs SH
Radiology; 1996 Oct; 201(1):185-93. PubMed ID: 8816542
[TBL] [Abstract][Full Text] [Related]
14. The variability of fibroadenoma in contrast-enhanced dynamic MR mammography.
Brinck U; Fischer U; Korabiowska M; Jutrowski M; Schauer A; Grabbe E
AJR Am J Roentgenol; 1997 May; 168(5):1331-4. PubMed ID: 9129437
[No Abstract] [Full Text] [Related]
15. Laser therapy for breast cancer: MR imaging and histopathologic correlation.
Mumtaz H; Hall-Craggs MA; Wotherspoon A; Paley M; Buonaccorsi G; Amin Z; Wilkinson I; Kissin MW; Davidson TI; Taylor I; Bown SG
Radiology; 1996 Sep; 200(3):651-8. PubMed ID: 8756910
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional gadolinium-enhanced MR imaging of the breast: pulse sequence with fat suppression and magnetization transfer contrast. Work in progress.
Pierce WB; Harms SE; Flamig DP; Griffey RH; Evans WP; Hagans JE
Radiology; 1991 Dec; 181(3):757-63. PubMed ID: 1947093
[TBL] [Abstract][Full Text] [Related]
17. Ovarian lesions: detection and characterization with gadolinium-enhanced MR imaging at 1.5 T.
Stevens SK; Hricak H; Stern JL
Radiology; 1991 Nov; 181(2):481-8. PubMed ID: 1924792
[TBL] [Abstract][Full Text] [Related]
18. Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses.
Semelka RC; Hricak H; Stevens SK; Finegold R; Tomei E; Carroll PR
Radiology; 1991 Mar; 178(3):803-9. PubMed ID: 1994422
[TBL] [Abstract][Full Text] [Related]
19. Breath-hold single-dose gadolinium-enhanced three-dimensional MR aortography: usefulness of a timing examination and MR power injector.
Earls JP; Rofsky NM; DeCorato DR; Krinsky GA; Weinreb JC
Radiology; 1996 Dec; 201(3):705-10. PubMed ID: 8939219
[TBL] [Abstract][Full Text] [Related]
20. [MR mammography at 0.5 tesla. II. The capacity to differentiate malignant and benign lesions in MR mammography at 0.5 and 1.5 T].
Kuhl CK; Kreft BP; Hauswirth A; Gieseke J; Elevelt A; Reiser M; Schild HH
Rofo; 1995 Jun; 162(6):482-91. PubMed ID: 7605960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
